The main objective of this study is to evaluate the effect of 3 months of "Snoezelen-type" multi-sensory care sessions on NeuroPsychiatric Inventory Questionnaire (NPI-Q) scores for patients with Alzheimer's-type neurodegenerative disease.

Patients hospitalized at the Serre-Cavalier centre and who have Alzheimer's-type neurodegenerative disease (see inclusion criteria).

Other: Multi-sensory supportive care

The Serre-Cavalier center will implement Snoezelen-type multisensory care sessions for included patients; these care sessions correspond with the patients' daily hygiene/toilette care.

The impact of this multisensory strategy will be evaluated using a before-after design.

Other Names:

Snoezelen-type care

Snoezelen toilette

Detailed Description:

The secondary objectives of this study are to study the following elements in relationship to the implementation of a "Snoezelen-type" multi-sensory care strategy for patients with Alzheimer's-type neurodegenerative disease:

The patient's legal representative must have given his/her informed and signed consent (or the patient if he/she is judged competent)

The patient must be insured or beneficiary of a health insurance plan

Alzheimer's-type neurodegenerative pathology

The patient has been living in the participating center for > 2 months

Exclusion Criteria:

The patient's legal representative refuses to sign the consent (or the patient if he/she is judged competent)

It is impossible to correctly inform the patient's legal representative

The patient has already has Snoezelen-therapy

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01819714